Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Corning Incorporated (GLW) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance

Corning IncorporatedTrade
Halozyme Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Corning Incorporated vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Corning Incorporated trades at $156.86 (market cap $131.65B), while Halozyme Therapeutics Inc. Common Stock trades at $112.3 (market cap $12.58B). The key difference: Corning Incorporated is far larger — about 10.5× Halozyme Therapeutics Inc. Common Stock's market cap, and Corning Incorporated pays a 0.73% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Corning Incorporated for 35 Days and Halozyme Therapeutics Inc. Common Stock for 0 Days on average.

GLWHALO
Market Cap
$131.65B$12.58B
Volume
8,992,5222,179,278
Sector
TechnologyHealth
52-Week High
$255.79$115.22
52-Week Low
$78.03$61.63
Typical Hold Time
35 Days0 Days
Enterprise Value
$138.52B$14.49B
Dividend Yield
0.73%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Corning Incorporated

Corning (GLW) trades at $155.95, down 4.45% today amid a bearish technical outlook despite strong fundamentals. The company recently secured a significant $3B+ fiber supply agreement with AT&T, boosting its optical communications segment. GLW has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Analyst consensus remains positive with a $171.25 price target, though technical indicators show selling pressure with support at $149 and resistance at $158.

GLW presents a compelling long-term opportunity with strong revenue growth projections and strategic positioning in fiber optics for AI infrastructure. However, elevated valuation multiples (P/E 70.43) and ongoing patent litigation investigations pose near-term risks. The stock's current technical weakness may offer entry points for investors bullish on the company's fiber optic expansion and AI-driven connectivity demand.

Halozyme Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GLW
89% Buy11% Sell
Avg holding period · 35 Days
HALO
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Corning Incorporated

Corning Inc is a leader in materials science, specializing in the production of glass, ceramics and optical fiber. The firm supplies its products for a wide range of applications, from flat-panel displays in televisions to gasoline particulate filters in automobiles to optical fiber for broadband access, with a leading share in many of its end markets.

Read more on GLW →

About Halozyme Therapeutics Inc. Common Stock

Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.

Read more on HALO →